AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Ydro 200mg Tablet

Prescription Icon
Prescription Required

Marketer

Arvincare Pharma

Salt Composition

Hydroxychloroquine (200mg)

Overview Ydro 200mg Tablet

Hydralazine 200mg tablets are indicated for managing autoimmune disorders like rheumatoid arthritis and lupus. This medication mitigates disease advancement and alleviates associated pain, inflammation, and erythema. It's also employed in type 2 diabetes to enhance blood sugar regulation. Administer Hydralazine 200mg with food to minimize gastrointestinal discomfort. Consistent daily dosing at the same time maximizes therapeutic efficacy. Continue the prescribed regimen as directed, even with symptom improvement. Common adverse effects include nausea, emesis, diarrhea, and stomach pain. Persistent or worsening side effects warrant medical attention; your physician can offer strategies for symptom management. Prior to initiating treatment, inform your doctor of any pre-existing cardiac, renal, or hepatic conditions, as well as all other medications. This medication is contraindicated in patients with visual disturbances and is not recommended for prolonged pediatric use. Regular ophthalmologic examinations may be advised during treatment. Pregnant or lactating individuals should seek medical counsel before using Hydralazine.

Uses of Ydro 200mg Tablet

Management of type 2 diabetes | Rheumatoid arthritis therapy | Systemic lupus erythematosus (SLE) management

Major Benefits of Ydro 200mg Tablet:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Ydro 200mg tablets should be administered with food.

Common Side effects of Ydro 200mg Tablet:

  • Skin rash
  • Itching
  • Affect lability
  • Abdominal pain
  • Blurred vision
  • Headache
  • Decreased appetite
  • Diarrhea
  • Vomiting
  • Nausea

How to use Ydro 200mg Tablet:

Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment schedule. Ingest the 200mg Ydro Tablet whole; avoid chewing, crushing, or fracturing it. It should be taken with a meal.

How Ydro 200mg Tablet works:

Arthrocin 200mg tablets function as a disease-modifying antirheumatic medication (DMARD), mitigating the excessive immune response responsible for joint inflammation and pain. This action inhibits the underlying disease's advancement. Furthermore, preliminary evidence indicates that this medication may enhance insulin responsiveness and pancreatic beta-cell activity, potentially leading to improved blood sugar management in individuals with type 2 diabetes.

SAFETY ADVICE

AlcoholAlcoholCAUTION

Use caution when combining Ydro 200mg Tablet with alcohol. Physician consultation is recommended.

PregnancyPregnancySAFE IF PRESCRIBED

Pregnancy use of Ydro 200mg Tablets is considered safe. Research largely indicates minimal or absent risk to the fetus.

Breast feedingBreast feedingSAFE IF PRESCRIBED

Lactation and Ydro 200mg tablets are compatible. Research in humans indicates minimal drug transfer to breast milk, posing no apparent risk to infants.

DrivingDrivingUNSAFE

Driving ability may be impaired by Ydro 200mg Tablet side effects, including potential vision problems.

KidneyKidneyCAUTION

Patients with kidney impairment should use Ydro 200mg Tablets cautiously, potentially requiring dosage modification. Physician consultation is advised. This medication may impact vision; routine eye examinations are recommended during treatment.

LiverLiverCAUTION

Individuals with hepatic impairment should use Ydro 200mg tablets cautiously. Dosage modification may be necessary; physician consultation is advised.

What if you forget to take Ydro 200mg Tablet :

Should you forget a Ydro 200mg Tablet dose, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Ydro 200mg Tablet

LabelValue
Type of Compound Quinoline-4-amine Analog
Potential for Dependence None.
Type of Medication Medication for Pain Relief

FAQs on Ydro 200mg Tablet

Research on Ydro 200mg tablets is ongoing, involving human clinical trials to assess its potential for preventing and treating COVID-19. Preclinical laboratory testing has demonstrated some antiviral activity against the novel coronavirus. Nonetheless, conclusive evidence of Ydro 200mg tablets' efficacy against the virus is still pending.
India's COVID-19 task force (under the ICMR) advises Ydro 200mg tablets for novel coronavirus prevention solely within specific high-risk groups (individuals with substantial virus exposure risk) or emergencies. Prophylactic use is suggested for asymptomatic healthcare personnel treating suspected or confirmed COVID-19 cases, and asymptomatic household members of confirmed cases.
We do not carry Ydro 200mg Tablets. If you believe you have a novel coronavirus infection, seek immediate medical attention and adhere to your physician's instructions. Avoid self-medicating with Ydro 200mg Tablets; this medication should only be used under the direction of a licensed doctor.
Administration of Ydro 200mg tablets is indicated solely for coronavirus prophylaxis in specified high-risk populations or urgent circumstances. Adherence to the physician's prescribed dosage, regimen, and treatment period is mandatory.
The 200mg Ydro tablet is an oral medication. Administer it with food or milk to minimize stomach upset and nausea. Follow your physician's prescribed dosage and duration, completing the entire course. Consistent use, as directed by your doctor, is crucial. Do not discontinue treatment without prior consultation. If also using antacids, separate Ydro 200mg tablet administration by at least four hours.
Individuals using Ydro 200mg Tablets who experience symptoms consistent with a novel coronavirus infection—including fever, dry cough, fatigue, or respiratory distress—must seek immediate medical attention. A physician will determine the need for COVID-19 testing and isolation, and all their recommendations should be followed carefully.
Hydroxychloroquine's therapeutic impact unfolds gradually. Symptom alleviation in rheumatoid arthritis and similar autoimmune conditions might not become apparent for several weeks, or even months. Consistent adherence to the prescribed regimen is crucial. Bridge therapy with supplementary medications may be provided by your physician to manage immediate symptom discomfort.
While infrequent, hydroxychloroquine (HCQS) can impact vision, particularly with higher dosages or prolonged use exceeding five years. Visual disturbances might manifest as difficulty reading or perceiving details (missing words, letters, or portions of objects), photosensitivity, blurred distance vision, and the appearance of flashing lights or streaks. Report any such symptoms to your physician immediately. They may perform ophthalmological examinations and determine if discontinuation of the Ydro 200mg Tablet is necessary. Regular eye exams might also be recommended for individuals prescribed HCQS.
Prior to commencing HCQS therapy, an ophthalmological examination is mandatory and should be repeated annually. Regular blood tests, including a complete blood count (CBC) and liver function tests (LFTs), may also be recommended by your physician. Treatment with HCQS may be ceased if any irregularities are identified.
The antimalarial drug, Ydro 200mg Tablet, possesses anti-inflammatory and immunomodulatory effects. This medication is not a steroid, opioid, or analgesic. In malaria, it eradicates the causative parasite. For rheumatoid arthritis, it alleviates joint inflammation and offers symptomatic relief.
Concurrent use of ibuprofen and hydroxychloroquine is acceptable; these medications lack clinically significant interactions and do not demonstrably affect each other's efficacy.
Discontinuing HCQS treatment prematurely, without physician guidance, may exacerbate your condition. Consequently, do not discontinue HCQS unless advised by your doctor, regardless of any perceived improvement in symptoms.
Individuals with diabetes require caution when taking HCQS. This medication can significantly reduce blood sugar, potentially causing severe hypoglycemia and loss of consciousness. Closely monitor blood glucose levels; if they drop, seek immediate medical attention. Your physician may adjust your diabetes medications based on your blood sugar readings.
HCQS can be taken, but ensure a minimum four-hour interval between its administration and any antacid medication. Failure to observe this spacing may compromise HCQS absorption and efficacy, potentially reducing its therapeutic effect.
Clinical trials are evaluating Ydro 200mg Tablet for both preventing novel coronavirus infection and treating COVID-19. Preliminary laboratory research indicates some antiviral activity. Nevertheless, conclusive evidence of Ydro 200mg Tablet's efficacy against the novel coronavirus is still pending.
India's COVID-19 task force (under the ICMR) advises Ydro 200mg tablets solely for preventing novel coronavirus infection within specific high-risk groups (individuals with heightened virus exposure risk) or during emergencies. Prophylactic use is suggested for asymptomatic healthcare personnel treating suspected or confirmed COVID-19 patients, and asymptomatic household members of confirmed cases.
We do not carry Ydro 200mg Tablets. If you believe you may have COVID-19, seek immediate medical attention and adhere to your physician's instructions. Avoid self-treating with Ydro 200mg Tablets; this medication should only be used under the direction of a licensed healthcare professional.
Use of Ydro 200mg tablets is limited to coronavirus prevention in specified high-risk populations or urgent circumstances. Adherence to the physician's prescribed dosage, schedule, and treatment length is mandatory.
Hydrobromide 200mg tablets are administered orally. To minimize gastrointestinal distress, ingestion should coincide with a meal or milk. Adhere strictly to the prescribed dosage and treatment schedule, completing the full course. Consistent daily use, as directed by your physician, is crucial. Discontinuation should only occur with prior medical consultation. If also using antacids, maintain a four-hour interval between their administration and that of the 200mg tablets.
Individuals using Ydro 200mg Tablets who experience symptoms consistent with novel coronavirus infection—including fever, cough, fatigue, or respiratory distress—must contact their physician promptly. The physician will determine the need for COVID-19 testing and isolation, and patients should adhere to all recommended medical guidance.
Hydroxychloroquine's therapeutic impact unfolds gradually. Symptom improvement in rheumatoid arthritis and similar autoimmune conditions might not be evident for several weeks, or even months. Consistent adherence to the prescribed dosage is crucial. Bridge therapy with supplementary medications might be offered by your physician to manage symptoms until the primary medication takes full effect.
While infrequent, hydroxychloroquine (HCQS) can impact vision, particularly with higher dosages or prolonged use (exceeding five years). Visual disturbances may manifest as difficulty reading or perceiving details (missing words, letters, or object parts), photosensitivity, blurred distance vision, and the perception of flashing or streaking lights. Report any such symptoms promptly to your physician. They may conduct ophthalmological examinations and determine if discontinuation of the Ydro 200mg Tablet is necessary. Regular eye examinations might also be recommended for individuals on a long-term HCQS prescription.
Prior to commencing HCQS therapy, an ophthalmologic examination is mandatory, and should be re-administered annually. Periodic blood cell counts (CBC) and liver function assessments (LFT) may also be recommended by your physician. Treatment with HCQS may be ceased if any irregular results are identified.
The antimalarial drug, Ydro 200mg Tablet, possesses anti-inflammatory and immunomodulatory effects. This medication is not a steroid, opioid, or analgesic. In cases of malaria, Ydro 200mg Tablet eliminates the causative parasite. Conversely, in rheumatoid arthritis, it mitigates joint inflammation and offers symptomatic relief.
Concurrent use of ibuprofen and HCQS is acceptable; these medications lack significant interactive effects.
Discontinuing HCQS treatment prematurely, without physician guidance, could exacerbate your condition. Consequently, do not discontinue HCQS unless your doctor advises you to do so, regardless of any perceived improvement in your symptoms.
Individuals with diabetes should exercise caution when taking HCQS. HCQS can significantly reduce blood glucose, potentially causing severe hypoglycemia and loss of consciousness. Frequent blood glucose monitoring is essential; if levels drop, seek immediate medical attention. Your physician may adjust your anti-diabetic medication dosage based on your glucose readings.
Taking HCQS is acceptable, but ensure a minimum four-hour interval between HCQS administration and antacid ingestion. Failure to observe this interval could hinder HCQS absorption and efficacy, potentially reducing its therapeutic effect.
Ydro 200mg Tablet
54
MRP 63
13% off